Health ❯ Healthcare

Neurodegenerative Diseases

Alzheimer's Disease Dementia Parkinson's Disease Cognitive Impairment Alzheimer's Research Research Multiple Sclerosis Amyotrophic Lateral Sclerosis Drug Development Clinical Trials Therapeutics Pathophysiology Diagnosis Optic Nerve Disorders Neuroprotection Genetic Disorders Amyloid Pathology Aphasia Research Innovations Mucopolysaccharidosis Esclerosis Lateral Amiotrófica Lewy Body Syndrome Diabetic Retinal Neurodegeneration

Estrogen-Only Menopausal Therapy Linked to Fewer Alzheimer’s Markers on Autopsy

Experts call the result associative not causal; they say randomized trials must test timing, formulation and subgroup effects

ProMIS Reports Blinded Six‑Month Interim Data Showing No ARIA‑E in PMN310 Phase 1b Trial

Blood Tests Map Decades-Long Alzheimer’s Changes and Point to Earlier Screening

Handwriting on Tablets Signals Cognitive Impairment in Care-Home Study

MIT Team Coaxes Chaotic Fiber Laser Into ‘Pencil Beam’ for Fast 3D Brain-Barrier Imaging

FDA Rejects Regenxbio’s Hunter Syndrome Gene Therapy Application

UK Approves Once-Every-Four-Weeks IV Maintenance Dosing for Leqembi in Early Alzheimer’s

Alector Ends Latozinemab After Phase 3 Failure, Slashes Workforce

First Noninvasive MRI Maps Brain’s Tiniest Vessel Pulses, Tying Aging and Hypertension to Deep White Matter

Eye and Blood Levels of SLIT2 Track Cognition in Middle-Aged Adults, Study Finds

Harvard Team Releases PDGrapher, an AI to Predict Gene and Drug Combos That Reverse Diseased Cell States

Alzheimer’s Biomarkers Emerge in Middle Age With Maternal and Kidney Associations

Ambroxol Trial Confirms Safety, Brain Delivery and Early Cognitive Benefits in Parkinson’s Dementia

FDA Approves First Eye Implant to Preserve Vision in Rare Macular Telangiectasia